Sophia Steve
Thyroid cancer is much more common than it was a few decades ago, with an estimated incidence of 20.0 occurrences per 100,000 women and 6.3 cases per 100,000 males in 2012. In Portugal and South Korea, thyroid cancer is already the third most prevalent cancer in women. In South Korea, thyroid cancer is currently the most common kind of cancer diagnosed. The likelihood of surviving for five years is high— more than 85%. But when differentiated thyroid carcinoma (DTC) is diagnosed, 1-4% of patients have distant disease, and 7-23% go on to develop metastatic illness. The patient's chance of life for 10 years is reduced by 50% by these metastases, which mostly affect the lungs and bones. Overall, 2-13% of individuals with DTC develop bone metastases (BM). The development of skeletal-related events (SRE), such as pathologic fractures, spinal cord compression, or the requirement for surgery or radiation, is another possibility for individuals with BM. This might worsen the prognosis and lower the patient's quality of life. Due to a number of characteristics, such as increased blood flow in regions with red marrow, the bone is a tissue that has a high propensity for metastases. The histological type most often linked to BM in the literature is follicular thyroid cancer (FTC). Radioiodine therapy (RAIT), surgery, radiation, and bisphosphonates are all possible treatments for BM.
KeywordsDistant metastasis;Follicular carcinoma; Pelvic Muscle; Thyroid; Follicular; Thyroid carcinoma; Metastasis; Iliac wing
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi